A pilot study using synthetic feline facial pheromone for the management of feline idiopathic cystitis

Journal of Feline Medicine and Surgery

Volumn 6, Issue 3, 2004, Pages 133-138

  Gunn Moore, Danielle A ^a   Cameron, M E ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Blairgowrie Veterinary Surgeons   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PHEROMONE; PLACEBO;

AGGRESSION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CAT DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; CYSTOGRAPHY; DISEASE SEVERITY; DYSURIA; FEAR; FEMALE; HEMATURIA; IDIOPATHIC DISEASE; INTERSTITIAL CYSTITIS; MALE; NONHUMAN; PHYSICAL EXAMINATION; PILOT STUDY; POLLAKISURIA; RANDOMIZATION; SCORING SYSTEM; ULTRASOUND; URINALYSIS; VISUAL ANALOG SCALE;

ANIMALIA; FELIDAE; FELIS CATUS;

EID: 2542530659     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfms.2004.01.006     Document Type: Article

References (33)

1. Barsanti, J.A., Brown, J., Marks, A., Reece, L., Greene, C.E., Finco, D.R., 1996. Relationship of lower urinary tract signs to seropositivity for feline immunodeficiency virus in cats. Journal of Veterinary Internal Medicine 10(1), 34-38.
2. Beaver, B.V., 1992. Feline communicative behavior, in: Feline Behavior: A Guide for Veterinarians. Philadelphia. WB Saunders, pp. 63-85.
3. Buffington, C.A.T., 2002. External and internal influences on disease risk in cats. Journal of the American Veterinary Medicine Association 220(7), 994-1001.
4. Buffington, C.A.T., Chew, D.J., Kendall, M., Scrivani, P.V., Thompson, S.B., Blaisdell, J.L., Woodworth, B.E., 1997. Clinical evaluation of cats with non-obstructive urinary tract disease. Journal of the American Veterinary Medicine Association 210(1), 46-50.
5. Buffington, C.A.T., Chew, D.J., Woodworth, A., 1999. Feline interstitial cystitis. Journal of the American Veterinary Medicine Association 215(5), 682-687.
6. Buffington, C.A.T., Pacak, K., 2001. Increased plasma norepinephrine concentration in cats with interstitial cystitis. Journal of Urology 165, 2051-2054.
7. Cameron, M.E., Casey, R.A., Bradshaw, J.W.S., Waran, N.K., Gunn-Moore, D.A., 2001. Inappropriate urination: A study of the environmental and behavioural factors involved in the triggering of idiopathic cystitis. Proceedings of BSAVA Congress, Birmingham, UK, p. 507.
8. Carlstead, K., Brown, J.L., Strawn, W., 1993. Behavioral and physiological correlates of stress in laboratory cats. Applied Animal Behavioural Science 38, 143-158.
9. Clauw, D.J., Chrousos, G.P., 1997. Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 4, 134.
10. Elbadawi, A., 1997. Interstitial cystitis: A critique of current concepts with a new proposal for pathologic diagnosis and pathogenesis. Urology 49(Supplement 5A), 14-40.
11. Frank, D.F., Erb, H.N., Houpt, K.A., 1999. Urine spraying in cats: presence of concurrent disease and effects of a pheromone treatment. Applied Animal Behaviour Science 61, 263-272.
12. Gaultier, E., Pageat, P., Tessier, Y., 1998. Effect of a feline appeasing pheromone analogue on manifestations of stress in cats during transport. Proceedings of the 32nd Congress of the International Society for Applied Ethology, Clermont-Ferrand, p. 198.
13. Griffith, C., Steigerwald, E.S., Buffington, C.A.T., 2000. Effects of a synthetic facial pheromone on behavior of cats. Journal of the American Veterinary Medicine Association 217(8), 1154-1156.
14. Hague, D., Buffington, C.A.T., 2003. Effects of feline interstitial cystitis on behavior of cats exposed to a novel cage environment. Proceedings of the 20th American College of Veterinary Internal Medicine, Dallas, Texas, p. 810.
15. Horwitz, D.F., 1997. Behavioral and environmental factors associated with elimination behavior problems in cats: a retrospective study. Applied Animal Behavioral Science 52, 129-137.
16. Hunthausen, W., 2000. Evaluating a feline facial pheromone analogue to control urine spraying. Veterinary Medicine 95, 151-155.
17. Jacobs, B.L., 1990. Locus coeruleus neuronal activity in behaving animals, in: Heal, D.J., Marsden, C.A. (Eds.), The Pharmacology of Noradrenaline in the Central Nervous System. New York. Oxford University Press, pp. 248.
18. Jones, B.R., Sanson, R.L., Morris, R.S., 1997. Elucidating the risk factors of feline lower urinary tract disease. New Zealand Veterinary Journal 45, 100-108.
19. Kalkstein, T.S., Kruger, J.M., Osborne, C.A., 1999. Feline idiopathic lower urinary tract disease. Part II. Potential causes. Compendium of Continuing Education for the Practising Veterinarian 21(2), 148-154.
20. Kruger, J.M., Osborne, C.A., Goyal, S.M., Wickstrom, S.L., Johnston, G.R., Fletcher, T.F., Brown, P.A., 1991. Clinical evaluation of cats with lower urinary tract disease. Journal of the American Veterinary Medicine Association 199, 211-216.
21. Lekcharoensuk, C., Osborne, C., Lulich, J., 2001. Epidemiological study of risk factors for lower urinary tract diseases in cats. Journal of the American Veterinary Medicine Association 218(9), 1429-1435.
22. McCune, S., 1995. Environmental enrichment for cats - a review. Proceedings of the Second International Conference of Environmental Enrichment, pp. 103-117.
23. Mills, D.S., Mills, C.B., 2001. Evaluation of a novel method for delivering a synthetic feline facial pheromone to control urine spraying by cats. Veterinary Record 149, 197-199.
24. Mills, D.S., White, J.C., 2000. Long-term follow up of the effect of a pheromone therapy on feline spraying behaviour. Veterinary Record 147, 746-747.
25. Ogata, N., Takeuchi, Y., 2001. Clinical trial of a feline pheromone analogue for feline urine marking. Journal of Veterinary Medicine and Science 63(2), 157-161.
26. Overall, K.L., 1998. Tracing the roots of feline elimination disorders to aggression. Veterinary Medicine 93, 363-366.
27. Pageat, P., 1996. Functions and use of the facial pheromones in the treatment of urine marking in the cat. Interest of a structural analogue, in: Johnston, D., Waner, T. (Eds.), Proceedings and Abstracts of the XXIst Congress of the World Small Animal Veterinary Association, Jerusalem, Israel, pp. 197-198.
28. Pertovaara, A., 1993. Antinociception induced by alpha-2-adrenoceptor agonists, with special emphasis on medetomidine studies. Progress in Neurobiology 40, 691-709.
29. Reche-Junior, A., Buffington, C.A.T., 1998. Increased tyrosine hydroxylase immunoreactivity in the locus coeruleus of cats with interstitial cystitis. Journal of Urology 159(3), 1045-1048.
30. Rothrock, N.E., Lutgendorf, S.K., Kreder, K.J., Ratliff, T., Zimmerman, B., 2001. Stress and symptoms in patients with interstitial cystitis: a life stress model. Urology 57(3), 422-427.
31. 2-adrenoceptor-mediated signal transduction pathways. Proceedings of the 20th American College of Veterinary Internal Medicine, Dallas, Texas, p. 810.
32. Westropp, J.L., Buffington, C.A.T., 2002b. Uncoupling of the noradrenergic-hypothalamic-pituitary-adrenal axis in stressed cats with interstitial cystitis. Proceedings of the 20th American College of Veterinary Internal Medicine, Dallas, Texas, p. 813.
33. White, J.C., Mills, D.S., 1997. Efficacy of synthetic feline facial pheromone (F3) analogue (Feliway) for the treatment of chronic non-sexual urine spraying by the domestic cat, in: Mills, D.S., Heath, S.E., Harrington, L.J. (Eds.), Proceedings of the First International Conference on Veterinary Behavioural Medicine. Potters Bar. Universities Federation for Animal Welfare, pp. 242.